Peter Vozzo | Westwicke Partners |
Jack Khattar | Founder, President, CEO, Secretary & Director |
James Kelly | EVP & CFO |
Kenneth Cacciatore | Cowen and Company |
David Amsellem | Piper Sandler & Co. |
Nicholas Rubino | Stifel, Nicolaus & Company |
David Steinberg | Jefferies |
Good afternoon, and welcome to Supernus Pharmaceuticals' First Quarter 2021 Financial Results Conference Call. [Operator Instructions]. I would now like to turn the conference over to Peter Vozzo of Westwicke, Investor Relations representative for Supernus Pharmaceuticals.
You may begin.
Thank you, Jurgen.